Potency is more than
just a number

OMNi-BiOTiC® offers science backed
performance.

The Omni-Biotic Difference

Significance

Every OMNi-BiOTiC strain is identified and extensively analyzed to determine its strengths and suitability for gastro-intestinal support in order to create probiotics tailored to specific health goals.

Synergy

The multispecies OMNi-BiOTiC formulations are powered for synergistic activity, validated through lab models and controlled human clinical studies.

Survival

OMNi-BiOTiC is tested for gastric survival, intestinal viability, metabolic activity, and extended real time shelf stability. Its powder form is over 90% more effective than a probiotic pill/capsule.

Our Quality Process

Phase I: Strain Significance

Within each species of bacteria there is a multitude of strains. Some strains within a given species are strong and resilient, with a demonstrated capacity to survive the trip through the upper GIT, interact with the immune system, and inhibit pathogenic bacteria, whereas other strains are weak.

Jason Hawreleck, PhD Head of Research, Probiotic Advisor

We understand the jobs at which our strains excel and formulate products to take advantage of the strengths and synergistic interactions of each.

From the beginning, Omni-Biotic human sourced probiotics are deeply evaluated at the bench level to elucidate mechanistic strain strengths including:

Products

During pregnancy, a woman’s gut microbiome changes considerably from the first to the third trimester, with an overall reduction in microbial diversity. These changes have been associated with a variety of undesirable health effects for mom. Moreover, the maternal gut, placenta, and vaginal microbiome are vital to fetal immunological health and development. There is also increasing evidence linking reduced fetal microbial exposure and diversity to the development of allergic conditions in childhood. 

Controlled human studies have demonstrated the ability of Omni-Biotic PandA to positively alter both the maternal and neonatal microbiota.

During pregnancy, a woman’s gut microbiome changes considerably from the first to the third trimester, with an overall reduction in microbial diversity. These changes have been associated with a variety of undesirable health effects for mom. Moreover, the maternal gut, placenta, and vaginal microbiome are vital to fetal immunological health and development. There is also increasing evidence linking reduced fetal microbial exposure and diversity to the development of allergic conditions in childhood. 

Controlled human studies have demonstrated the ability of Omni-Biotic PandA to positively alter both the maternal and neonatal microbiota.

SCIENTIFIC PUBLICATIONS

Omni-Biotic Development and Manufacturing Process

Omni-Biotic Stress Release

Anita Frauwallner Headshot 2 Square

ABOUT

Institut AllergoSan, a leader in probiotic research and formulation, has served European pharmacies and practitioners for more than 25 years. In partnership with AllergoSan USA, their evidence-based formulations are now available to American practitioners. The Omni-Biotic line is uniquely aligned with the company’s commitment to the highest quality, research, and evidence standards. This equates to every strain being identified and analyzed in vitro to determine its particular mechanistic strengths. Every formulation is further designed and tested for synergistic performance, both in preclinical and controlled human trials. Each product also undergoes gastric resistance and metabolic activity analysis as well as extended real-time stability testing to ensure every serving delivers at full potency. Hypoallergenic and individually packaged for protection, portability, and convenience, request your complimentary samples HERE

Sign Up Now
Enter email to be notified when the new shipment of Omni-Logic PLUS is available.
Sign Up & Save
Subscribe to our email newsletter and enjoy 10% off your next order.